Andrew D. Dickinson

Gilead Sciences, Inc.

Assets Managed

$2.118B

Holdings

Last Quarter

2026 - Q1

Filed Date

18d ago

Growth Rate

9.42%(2Q avg: 8.73%)

Sustained Growth

4 quarters

Portfolio positions

This chart displays the top 10 holdings in Gilead Sciences, Inc.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 6 positions.

Assets under management

The assets under management (AUM) of Gilead Sciences, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 2.118B in assets, with a quarterly growth rate of 9.42% and a 2-quarter average growth rate of 8.73%. The portfolio is managed by Andrew D. Dickinson, and others.

Portfolio holdings

Investment	Portfolio %	Reported Value	Recent Activity
ACLX Arcellx Inc Recent Activity	36.44%	$771.683M 6.721M shares@ $114.82 avg price
RCUS Arcus Biosciences Inc Recent Activity	32.06%	$678.775M 31.425M shares@ $21.6 avg price
GLPG Galapagos Nv-spon Adr Recent Activity	23.67%	$501.224M 16.707M shares@ $30.0 avg price
ASMB Assembly Biosciences Inc Recent Activity	5.91%	$125.025M 4.505M shares@ $27.75 avg price
KYTX Kyverna Therapeutics Inc Recent Activity	1.69%	$35.608M 4.126M shares@ $8.64 avg price
XLO Xilio Therapeutics Inc Recent Activity Decreased -92.85%	0.26%	$5.47M 650,389 shares@ $8.41 avg price	Decreased -92.85%

1-6 of 6